Diagnosis and Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - A National Observational Study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Diagnosis and Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - A National Observational Study. / Jakobsen, Louise Kjersgaard; Jensen, Rikke Beck; Birkebæk, Niels Holtum; Hansen, Dorte; Christensen, Ann-Margrethe Rønholt; Bjerrum, Maja Carsting; Christesen, Henrik Thybo.

In: The Journal of clinical endocrinology and metabolism, Vol. 108, No. 10, 2023, p. 2475-2485.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jakobsen, LK, Jensen, RB, Birkebæk, NH, Hansen, D, Christensen, A-MR, Bjerrum, MC & Christesen, HT 2023, 'Diagnosis and Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - A National Observational Study', The Journal of clinical endocrinology and metabolism, vol. 108, no. 10, pp. 2475-2485. https://doi.org/10.1210/clinem/dgad198

APA

Jakobsen, L. K., Jensen, R. B., Birkebæk, N. H., Hansen, D., Christensen, A-M. R., Bjerrum, M. C., & Christesen, H. T. (2023). Diagnosis and Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - A National Observational Study. The Journal of clinical endocrinology and metabolism, 108(10), 2475-2485. https://doi.org/10.1210/clinem/dgad198

Vancouver

Jakobsen LK, Jensen RB, Birkebæk NH, Hansen D, Christensen A-MR, Bjerrum MC et al. Diagnosis and Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - A National Observational Study. The Journal of clinical endocrinology and metabolism. 2023;108(10):2475-2485. https://doi.org/10.1210/clinem/dgad198

Author

Jakobsen, Louise Kjersgaard ; Jensen, Rikke Beck ; Birkebæk, Niels Holtum ; Hansen, Dorte ; Christensen, Ann-Margrethe Rønholt ; Bjerrum, Maja Carsting ; Christesen, Henrik Thybo. / Diagnosis and Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - A National Observational Study. In: The Journal of clinical endocrinology and metabolism. 2023 ; Vol. 108, No. 10. pp. 2475-2485.

Bibtex

@article{d083e85df87846b8a29d40fb6c076500,
title = "Diagnosis and Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - A National Observational Study",
abstract = "CONTEXT: Congenital combined pituitary hormone deficiency (cCPHD) is the loss of ≥2 pituitary hormones caused by congenital factors.OBJECTIVE: We aimed to estimate the national incidence of cCPHD diagnosed before age 18 years and in subgroups.METHODS: Patients with cCPHD were identified in the Danish National Patient Registry and Danish hospital registries in the period 1996-2020. Hospital files were reviewed and incidences calculated using background population data. Incidence was the main outcome measure.RESULTS: We identified 128 patients with cCPHD; 88 (68.8%) were males. The median (range) age at diagnosis was 6.2 (0.01-19.0) years. The median (25th;75th percentile) number of hormone deficiencies at diagnosis was 3 (3; 4) at <1 year vs 2 (2; 2) at 1-17 years, P < .0001. Abnormal pituitary magnetic resonance imaging findings were seen in 70.3% (83/118). For those born in Denmark aged <18 years at diagnosis (n = 116/128) the estimated national incidence (95% CI) of cCPHD was 10.34 (7.79-13.72) per 100 000 births, with an annual incidence rate of 5.74 (4.33-7.62) per million. In subgroup analysis (diagnosis <1 vs 1-17 years), the incidence was highest in the 1-17 years subgroup, 7.97 (5.77-11.00) vs 1.98 (1.39-2.84) per 100 000 births, whereas the annual incidence rate was highest at <1 year, 19.8 (13.9-28.4) vs 4.69 (3.39-6.47) per million births.CONCLUSION: cCPHD had the highest incidence rate and the most hormone deficiencies in those diagnosed at <1 year. The incidence was highest in the 1-17 years age group, underscoring the need for multiple pituitary hormone investigations throughout childhood and adolescence in children with only 1 hormone deficiency.",
keywords = "Male, Child, Female, Adolescent, Humans, Infant, Child, Preschool, Incidence, Hypopituitarism/diagnosis, Pituitary Hormones, Denmark/epidemiology",
author = "Jakobsen, {Louise Kjersgaard} and Jensen, {Rikke Beck} and Birkeb{\ae}k, {Niels Holtum} and Dorte Hansen and Christensen, {Ann-Margrethe R{\o}nholt} and Bjerrum, {Maja Carsting} and Christesen, {Henrik Thybo}",
note = "{\textcopyright} The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.",
year = "2023",
doi = "10.1210/clinem/dgad198",
language = "English",
volume = "108",
pages = "2475--2485",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "10",

}

RIS

TY - JOUR

T1 - Diagnosis and Incidence of Congenital Combined Pituitary Hormone Deficiency in Denmark - A National Observational Study

AU - Jakobsen, Louise Kjersgaard

AU - Jensen, Rikke Beck

AU - Birkebæk, Niels Holtum

AU - Hansen, Dorte

AU - Christensen, Ann-Margrethe Rønholt

AU - Bjerrum, Maja Carsting

AU - Christesen, Henrik Thybo

N1 - © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

PY - 2023

Y1 - 2023

N2 - CONTEXT: Congenital combined pituitary hormone deficiency (cCPHD) is the loss of ≥2 pituitary hormones caused by congenital factors.OBJECTIVE: We aimed to estimate the national incidence of cCPHD diagnosed before age 18 years and in subgroups.METHODS: Patients with cCPHD were identified in the Danish National Patient Registry and Danish hospital registries in the period 1996-2020. Hospital files were reviewed and incidences calculated using background population data. Incidence was the main outcome measure.RESULTS: We identified 128 patients with cCPHD; 88 (68.8%) were males. The median (range) age at diagnosis was 6.2 (0.01-19.0) years. The median (25th;75th percentile) number of hormone deficiencies at diagnosis was 3 (3; 4) at <1 year vs 2 (2; 2) at 1-17 years, P < .0001. Abnormal pituitary magnetic resonance imaging findings were seen in 70.3% (83/118). For those born in Denmark aged <18 years at diagnosis (n = 116/128) the estimated national incidence (95% CI) of cCPHD was 10.34 (7.79-13.72) per 100 000 births, with an annual incidence rate of 5.74 (4.33-7.62) per million. In subgroup analysis (diagnosis <1 vs 1-17 years), the incidence was highest in the 1-17 years subgroup, 7.97 (5.77-11.00) vs 1.98 (1.39-2.84) per 100 000 births, whereas the annual incidence rate was highest at <1 year, 19.8 (13.9-28.4) vs 4.69 (3.39-6.47) per million births.CONCLUSION: cCPHD had the highest incidence rate and the most hormone deficiencies in those diagnosed at <1 year. The incidence was highest in the 1-17 years age group, underscoring the need for multiple pituitary hormone investigations throughout childhood and adolescence in children with only 1 hormone deficiency.

AB - CONTEXT: Congenital combined pituitary hormone deficiency (cCPHD) is the loss of ≥2 pituitary hormones caused by congenital factors.OBJECTIVE: We aimed to estimate the national incidence of cCPHD diagnosed before age 18 years and in subgroups.METHODS: Patients with cCPHD were identified in the Danish National Patient Registry and Danish hospital registries in the period 1996-2020. Hospital files were reviewed and incidences calculated using background population data. Incidence was the main outcome measure.RESULTS: We identified 128 patients with cCPHD; 88 (68.8%) were males. The median (range) age at diagnosis was 6.2 (0.01-19.0) years. The median (25th;75th percentile) number of hormone deficiencies at diagnosis was 3 (3; 4) at <1 year vs 2 (2; 2) at 1-17 years, P < .0001. Abnormal pituitary magnetic resonance imaging findings were seen in 70.3% (83/118). For those born in Denmark aged <18 years at diagnosis (n = 116/128) the estimated national incidence (95% CI) of cCPHD was 10.34 (7.79-13.72) per 100 000 births, with an annual incidence rate of 5.74 (4.33-7.62) per million. In subgroup analysis (diagnosis <1 vs 1-17 years), the incidence was highest in the 1-17 years subgroup, 7.97 (5.77-11.00) vs 1.98 (1.39-2.84) per 100 000 births, whereas the annual incidence rate was highest at <1 year, 19.8 (13.9-28.4) vs 4.69 (3.39-6.47) per million births.CONCLUSION: cCPHD had the highest incidence rate and the most hormone deficiencies in those diagnosed at <1 year. The incidence was highest in the 1-17 years age group, underscoring the need for multiple pituitary hormone investigations throughout childhood and adolescence in children with only 1 hormone deficiency.

KW - Male

KW - Child

KW - Female

KW - Adolescent

KW - Humans

KW - Infant

KW - Child, Preschool

KW - Incidence

KW - Hypopituitarism/diagnosis

KW - Pituitary Hormones

KW - Denmark/epidemiology

U2 - 10.1210/clinem/dgad198

DO - 10.1210/clinem/dgad198

M3 - Journal article

C2 - 37043518

VL - 108

SP - 2475

EP - 2485

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -

ID: 386608581